Ethyl Nipecotate CAS 5006-62-2 Assay ≥99.0% (GC) Foto egosipụtara dị elu

Ethyl Nipecotate CAS 5006-62-2 Assay ≥99.0% (GC) Ogo dị elu

Nkọwa dị mkpirikpi:

Aha Chemical: Ethyl Nipecotate

Ọnọdụ: 5006-62-2

Ọdịdị: Mmiri na-acha odo odo enweghị agba

Nyocha: ≥99.0% (GC)

Ogo dị elu, mmepụta azụmahịa

E-mail: alvin@ruifuchem.com

Zitere anyị email

Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Nye ya na ịdị ọcha dị elu yana ịdị mma kwụsie ike
Aha Chemical: Ethyl Nipecotate
Ọnọdụ: 5006-62-2
Ogo dị elu, mmepụta azụmahịa

Njirimara kemịkalụ:

Aha Chemical	Ethyl Nipecotate
Ụdị okwu	Ethyl 3-Piperidinecarboxylate;ethyl piperidine-3-carboxylate;3-Piperidinecarboxylic Acid Ethyl Ester
Nọmba CAS	5006-62-2
Nọmba CAT	RF-PI271
Ọnọdụ Ahịa	N'ọkwa, Mpụta Ihe ruru Tọn
Usoro ihe omimi	C8H15NO2
Ibu molekụla	157.21
Ebe Na-agbaze	165.0 ~ 167.0 ℃
Ebe esi nri	102-104 ℃ / 7 mmHg (ọkụ)
Njupụta	1.012 g/ml na 25 ℃ (ọkụ)
Ntụgharị uche	n20/D 1.460 (ọkụ)
Mmiri Solubility	Na-enweghị atụ
Ọnọdụ mbupu	Ebugara n'okpuru okpomọkụ gburugburu
Ụdị	Ruifu Chemical

Nkọwapụta:

Ihe	Nkọwapụta
Ọdịdị	Mmiri mmiri na-acha odo odo enweghị agba
Mmiri	≤0.50%
Otu adịghị ọcha	≤0.50%
Mgbakọta adịghị ọcha	≤1.0%
Ọla dị arọ	≤20ppm
Nyocha	≥99.0%
Nlele ọkọlọtọ	Standardkpụrụ ụlọ ọrụ
Ojiji	Ndị na-ahụ maka ọgwụ

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Barrel, 25kg / gbọmgbọm, ma ọ bụ dị ka ndị ahịa chọrọ.

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe pụọ na ọkụ, mmiri mmiri na ọrịa nje.

Uru:

Ajụjụ:

Ngwa:

Shanghai Ruifu Chemical Co., Ltd. bụ onye na-emepụta ihe na onye na-ebubata Ethyl Nipecotate (CAS: 5006-62-2) nwere àgwà dị elu, nke a na-ejikarị eme ihe na njikọ organic, njikọ nke intermediates ọgwụ na Active Pharmaceutical Ingredient (API).

A na-eji ngwa Ethyl Nipecotate (CAS: 5006-62-2) mee ihe na njikọ nke: α, α'-bis [3- (N, N-diethylcarbamoyl) -piperidino] -p-xylene;2-amino-4-thiazolyl nke 3- (iso-propyl-3-piperidinyl) phenol;

Reactant maka njikọ nke: Squalene synthase inhibitors;4-aminomethyl-7,8-dihydroxycoumarines na ether ether okpueze ha;Spiroimidazolidinone NPC1L1 inhibitors;modulators kworum mmetụta;Nhọrọ nke serotonin 5-HT6 ndị na-anabata ihe;Oxazolidinone RNA na-ejikọta ihe.